LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
PureTech
PureTech
Celldex Therapeutics
Klus Pharma Inc.
Xencor, Inc.
MacroGenics
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
City of Hope Medical Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center